January 2024
1. PRICE DJ, Nekkab N, Monteiro WM, Villela DAM, et al
   Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model.
   PLoS Med. 2024;21:e1004255.
   

   >> Share

   
   November 2023
2. ZAW AS, Win ESS, Yan SW, Thein KS, et al
   Successful elimination of falciparum malaria following the introduction of community-based health workers in Eastern Myanmar: A retrospective analysis.
   PLoS Med. 2023;20:e1004318.
   

   >> Share

   
   
3. WATSON JA, Peto TJ, White NJ
   Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria.
   PLoS Med. 2023;20:e1004312.
   

   >> Share

   
   April 2023
4. SIGNORELL A, Awor P, Okitawutshu J, Tshefu A, et al
   Correction: Health worker compliance with severe malaria treatment guidelines in the context of implementing pre-referral rectal artesunate in the Democratic Republic of the Congo, Nigeria, and Uganda: An operational study.
   PLoS Med. 2023;20:e1004234.
   

   >> Share

   
   February 2023
5. SIGNORELL A, Awor P, Okitawutshu J, Tshefu A, et al
   Health worker compliance with severe malaria treatment guidelines in the context of implementing pre-referral rectal artesunate in the Democratic Republic of the Congo, Nigeria, and Uganda: An operational study.
   PLoS Med. 2023;20:e1004189.
   

   >> Share

   
   October 2022
6. TAYLOR SM, Korwa S, Wu A, Gree CL, et al
   Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
   PLoS Med. 2022;19:e1004104.
   

   >> Share

   
   September 2022
7. PONS-DURAN C, Mombo-Ngoma G, Macete E, Desai M, et al
   Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trials.
   PLoS Med. 2022;19:e1004084.
   

   >> Share

   
   May 2022
8. NYAMWAYA DK, Otiende M, Mwango L, Kariuki SM, et al
   Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort study.
   PLoS Med. 2022;19:e1003994.
   

   >> Share

   
   January 2022
9. PHYO AP, Dahal P, Mayxay M, Ashley EA, et al
   Clinical impact of vivax malaria: A collection review.
   PLoS Med. 2022;19:e1003890.
   

   >> Share

   
   October 2021
10. BATTLE KE, Baird JK
    The global burden of Plasmodium vivax malaria is obscure and insidious.
    PLoS Med. 2021;18:e1003799.
    

    >> Share

    
    September 2021
11. CAIRNS M, Ceesay SJ, Sagara I, Zongo I, et al
    Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in 5 countries.
    PLoS Med. 2021;18:e1003727.
    

    >> Share

    
    
12. WECKMAN AM, Conroy AL, Madanitsa M, Gnaneswaran B, et al
    Neurocognitive outcomes in Malawian children exposed to malaria during pregnancy: An observational birth cohort study.
    PLoS Med. 2021;18:e1003701.
    

    >> Share

    
    
13. HENDRIXSON DT, Smith K, Lasowski P, Callaghan-Gillespie M, et al
    A novel intervention combining supplementary food and infection control measures to improve birth outcomes in undernourished pregnant women in Sierra Leone: A randomized, controlled clinical effectiveness trial.
    PLoS Med. 2021;18:e1003618.
    

    >> Share

    
    June 2021
14. DEVINE A, Battle KE, Meagher N, Howes RE, et al
    Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    PLoS Med. 2021;18:e1003614.
    

    >> Share

    
    
15. TONA LUTETE G, Mombo-Ngoma G, Assi SB, Bigoga JD, et al
    Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study.
    PLoS Med. 2021;18:e1003669.
    

    >> Share

    
    May 2021
16. WOODFORD J, Gillman A, Jenvey P, Roberts J, et al
    Positron emission tomography and magnetic resonance imaging in experimental human malaria to identify organ-specific changes in morphology and glucose metabolism: A prospective cohort study.
    PLoS Med. 2021;18:e1003567.
    

    >> Share

    
    
17. KHO S, Qotrunnada L, Leonardo L, Andries B, et al
    Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study.
    PLoS Med. 2021;18:e1003632.
    

    >> Share

    
    April 2021
18. CHAVATTE JM, Snounou G
    Controlled human malaria infection-Maker and breaker of dogma.
    PLoS Med. 2021;18:e1003591.
    

    >> Share

    
    
19. THRIEMER K, Ley B, von Seidlein L
    Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.
    PLoS Med. 2021;18:e1003494.
    

    >> Share

    
    
20. CHU CS, White NJ
    The prevention and treatment of Plasmodium vivax malaria.
    PLoS Med. 2021;18:e1003561.
    

    >> Share

    
    
21. VON SEIDLEIN L, White NJ
    Taking on Plasmodium vivax malaria: A timely and important challenge.
    PLoS Med. 2021;18:e1003593.
    

    >> Share

    
    
22. LEY B, Alam MS, Kibria MG, Marfurt J, et al
    Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh.
    PLoS Med. 2021;18:e1003576.
    

    >> Share

    
    
23. NEKKAB N, Lana R, Lacerda M, Obadia T, et al
    Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
    PLoS Med. 2021;18:e1003535.
    

    >> Share

    
    
24. AUBURN S, Cheng Q, Marfurt J, Price RN, et al
    The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools.
    PLoS Med. 2021;18:e1003560.
    

    >> Share

    
    November 2020
25. HOSSAIN MS, Commons RJ, Douglas NM, Thriemer K, et al
    The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
    PLoS Med. 2020;17:e1003393.
    

    >> Share

    
    
26. HOGAN AB, Winskill P, Ghani AC
    Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
    PLoS Med. 2020;17:e1003377.
    

    >> Share

    
    October 2020
27. MOUSA A, Al-Taiar A, Anstey NM, Badaut C, et al
    The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysis.
    PLoS Med. 2020;17:e1003359.
    

    >> Share

    
    
28. STRESMAN G, Whittaker C, Slater HC, Bousema T, et al
    Quantifying Plasmodium falciparum infections clustering within households to inform household-based intervention strategies for malaria control programs: An observational study and meta-analysis from 41 malaria-endemic countries.
    PLoS Med. 2020;17:e1003370.
    

    >> Share

    
    September 2020
29. HARTLEY MA, Hofmann N, Keitel K, Kagoro F, et al
    Clinical relevance of low-density Plasmodium falciparum parasitemia in untreated febrile children: A cohort study.
    PLoS Med. 2020;17:e1003318.
    

    >> Share

    
    
30. LORENZ LM, Bradley J, Yukich J, Massue DJ, et al
    Comparative functional survival and equivalent annual cost of 3 long-lasting insecticidal net (LLIN) products in Tanzania: A randomised trial with 3-year follow up.
    PLoS Med. 2020;17:e1003248.
    

    >> Share

    
    
31. O'BRIEN KS, Arzika AM, Maliki R, Manzo F, et al
    Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger.
    PLoS Med. 2020;17:e1003285.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share